Piper Sandler Maintains Overweight on Illumina, Raises Price Target to $200
Piper Sandler analyst David Westenberg maintains Illumina (NASDAQ: ILMN ) with a Overweight and raises the price target from $170 to $200.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.